Medi-first Plus Sinus Decongestant Tablet, Film Coated
NDC Package 85766-182-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Medi-first Plus Sinus Decongestant (phenylephrine hydrochloride) tablets is usesTemporarily relieves■ nasal congestion due to the common cold, hay fever or other upper respiratory allergies■ sinus congestion and pressure. This formulation utilizes a tablet, film coated delivery system. Marketed by Sportpharm Llc, this product is identified by NDC 85766-182 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
85766-182-01
Package Description
100 PACKET in 1 BOX / 1 TABLET, FILM COATED in 1 PACKET
Product Code
85766-182
11-Digit Billing Format
85766018201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Medi-first Plus Sinus Decongestant
Non-Proprietary Name
Phenylephrine Hydrochloride
Substance Name
Phenylephrine Hydrochloride
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PHENYLEPHRINE HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
UsesTemporarily relieves■ nasal congestion due to the common cold, hay fever or other upper respiratory allergies■ sinus congestion and pressure

Regulatory & Marketing

Labeler Name
Sportpharm Llc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-07-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (85766-182). Click a package code to view its specific billing and regulatory data.

85766-182-25
250 PACKET in 1 BOX / 1 TABLET, FILM COATED in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85766-182-01 identifies a specific commercial package of 100 packet in 1 box / 1 tablet, film coated in 1 packet of Medi-first Plus Sinus Decongestant, a human over the counter drug labeled by Sportpharm Llc. This tablet, film coated is formulated for oral use and contains phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sportpharm Llc on March 07, 2026. The current certification is valid through December 31, 2027.

How is this Sportpharm Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85766018201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85766-182-01
11-Digit CMS (5-4-2)
85766-0182-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.